[ad_1]
The waves continue to rise when it comes to AstraZeneca’s corona vaccine. Austria’s Vaccination Committee again discussed the safety of the vaccine on Wednesday evening and came to the same conclusion as the WHO: the use of AstraZeneca is still recommended.
22.31, March 31, 2021
The Strategic Vaccination Council of World Health Organization (WHO) adheres to the Astrazeneca corona vaccine. Even after the German decision against the use of the agent in people under 60, he sees no reason to adjust his recommendations, said the director of the WHO vaccination department Kate O’Brien in Geneva on Wednesday.
Following the restriction of the use of AstraZeneca’s corona vaccine in Germany, the Explanation from the EU Medicines Agency (EMA)what are they currently no age-specific risks with the corona vaccine watch. I have an exam no specific risk factors such as age or gender for blood clots after an AszraZeneca vaccine, the EMA announced Wednesday in Amsterdam. But the tests would continue.
That too National Vaccination Board (NIG) He has been in Wednesday night back in the corona shot of AstraZeneca advised and recommended the continuation of the vaccination program with the vaccine in Austria. The situation of blood clots (thrombosis) in relation to vaccines is currently being evaluated in an ongoing procedure by the European Medicines Agency (EMA), it said in a statement. However, to date, the available data has not yet produced a homogeneous picture.
Additional evaluation after Easter
Data is continuously collected and analyzed from both the EU and Austria and Great Britain. In the week after Easter, at a PRAC / EMA meeting, all international data available up to that point should be examined, according to the NIG Safety Board statement. A statement from the EMA on AstraZeneca’s COVID-19 vaccine is then expected.
In Germany, the federal and state governments decided Tuesday to administer the AstraZeneca vaccine only to people 60 and older.The background is tragic cases of blood clots (thrombosis) in the cerebral veins in connection with vaccines. Austria continues to rely on the added value of the vaccine to contain the pandemic. The director of the NIG, Ursula Wiedermann-Schmidt, spoke on Tuesday evening in the “ZiB2” against the ban on vaccination in Austria. It is important to maintain the risk-benefit ratio.
Consultations from April 6 to 9
The European Medicines Agency (EMA) will be back next week Astrazeneca Vaccine Safety advise. A group of experts had already met on Monday. Your additional report and analysis should be presented at the meeting EMA discussed April 6-9 Will. Then an update of the EMA recommendation is expected, as announced by the EMA. The EMA safety committee had recently confirmed that the vaccine “safe and effective” and that there was no evidence of an increased risk of blood clots. The EMA had also stressed that experts would continue to examine cases of thrombosis.
Renamed AstraZeneca vaccine
Now it has also been known that the Swedish-British pharmaceutical company Astrazeneca your coronavirus vaccine in the EU with the name “VaxzevriaThe company announced this Wednesday that the new name has been approved by the European Medicines Agency (EMA), until now the preparation has been known as “Covid-19 Vaccine AstraZeneca”.
